40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
43.89%
Revenue growth above 1.5x MTDR's 23.43%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
30.11%
Gross profit growth at 50-75% of MTDR's 43.01%. Martin Whitman would question if cost structure or brand is lagging.
108.64%
EBIT growth above 1.5x MTDR's 54.75%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
108.64%
Operating income growth above 1.5x MTDR's 54.75%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
935.79%
Net income growth above 1.5x MTDR's 62.51%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
104.86%
EPS growth above 1.5x MTDR's 48.15%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
104.86%
Diluted EPS growth above 1.5x MTDR's 53.85%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.01%
Share reduction more than 1.5x MTDR's 7.02%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.01%
Diluted share reduction more than 1.5x MTDR's 6.95%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
1.99%
Dividend growth of 1.99% while MTDR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-9.26%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-52.66%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
15.95%
10Y revenue/share CAGR under 50% of MTDR's 545.08%. Michael Burry would suspect a lasting competitive disadvantage.
-40.32%
Negative 5Y CAGR while MTDR stands at 545.08%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-3.52%
Negative 3Y CAGR while MTDR stands at 246.40%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-17.95%
Negative 10Y OCF/share CAGR while MTDR stands at 400.10%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-73.84%
Negative 5Y OCF/share CAGR while MTDR is at 400.10%. Joel Greenblatt would question the firm’s operational model or cost structure.
-48.28%
Negative 3Y OCF/share CAGR while MTDR stands at 161.45%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
790.84%
Net income/share CAGR above 1.5x MTDR's 511.31% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
11281.02%
5Y net income/share CAGR above 1.5x MTDR's 511.31%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
2224.02%
3Y net income/share CAGR above 1.5x MTDR's 156.99%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-1.96%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-61.43%
Negative 5Y equity/share growth while MTDR is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-43.08%
Negative 3Y equity/share growth while MTDR is at 77.63%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
41.88%
Stable or rising dividend while MTDR is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
-82.77%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-65.53%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-0.08%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-100.00%
Inventory is declining while MTDR stands at 33.96%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
13.95%
Similar asset growth to MTDR's 12.70%. Walter Schloss finds parallel expansions or investment rates.
37.06%
Positive BV/share change while MTDR is negative. John Neff sees a clear edge over a competitor losing equity.
-1.84%
We’re deleveraging while MTDR stands at 66.67%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-11.85%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.